$UPXI
Upexi, Inc. Common Stock
XNAS•Financials•Finance Services
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is UPXI up today? It is at $1.20 (+13.74%), and our scanner flagged it 206 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment UPXI spikes, and full due diligence on UPXI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $UPXI 206 times in the last 30 days. Create a free account to track $UPXI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on UPXI from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystUpexi Reports Financial Results for Fiscal Year Ended June 30, 2026, from an SEC filing. Read it →Across every filing on file, supply equal to at least 18.4% of the tradeable float is in play - 18.4% has already been sold.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
12,242,300 new shares · Priced at $1.59652/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Norstrud Andrew James Officer | Acquired (grant/award) | +400K 0.5% of company | added 62% | 1.05M | n/a | Jul 3, 26 |
Marshall Allan Officer | Acquired (grant/award) | +2.00M 2.4% of company | added 49% | 6.05M | n/a | Jul 3, 26 |
Rudick Brian Benjamin Officer | Acquired (grant/award) | +400K 0.5% of company | added 48% | 1.24M | n/a | Jul 3, 26 |
Dugan Lawrence Director | Acquired (grant/award) | +100K 0.1% of company | added 86% | 216K | n/a | Jul 3, 26 |
Salkind Gene Director | Acquired (grant/award) | +100K 0.1% of company | added 46% | 319K | n/a | Jul 3, 26 |
Marshall Allan Officer | Bought (open market) | +50K 0.06% of company | added 1.3% | 4.05M | $90K at $1.80 | Dec 23, 25 |
Marshall Allan Officer | Bought (open market) | +50K 0.06% of company | added 1.3% | 4.00M | $103K at $2.07 | Dec 16, 25 |
Marshall Allan Officer | Bought (open market) | +100K 0.1% of company | added 2.6% | 3.95M | $207K at $2.07 | Dec 15, 25 |
Salkind Gene Director | Bought (open market) | +50K 0.06% of company | added 30% | 219K | $127K at $2.55 | Nov 20, 25 |
Salkind Gene Director | Bought (open market) | +100K 0.1% of company | added 21% | 569K | $265K at $2.65 | Nov 17, 25 |
Salkind Gene Director | Bought (open market) | +100K 0.1% of company | added 100% | 169K | $281K at $2.81 | Nov 17, 25 |
Norstrud Andrew James Officer | Acquired (grant/award) | +240K 0.3% of company | n/a | n/a | n/a | Oct 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Comparable names in finance services, closest in size first.
Here is the latest on UPXI from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
UPXI last traded at $1.20, up 13.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Upexi, Inc. Common Stock (UPXI) is next expected to report earnings on Tuesday, November 10, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The UPXI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged UPXI 206 times in the last 30 days.
UPXI (Upexi, Inc. Common Stock) trades on XNAS, with a market cap of about $87M in the Finance Services sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge UPXI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$UPXI discussion
Sign in to ask a question or join the discussion.